GEODE CAPITAL MANAGEMENT, LLC - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$467,931
+199870.5%
32,0940.0%0.00%
Q4 2022$234
-99.9%
32,0940.0%0.00%
Q3 2022$222,000
+6.7%
32,094
+7.4%
0.00%
Q2 2022$208,000
-15.4%
29,8790.0%0.00%
Q1 2022$246,000
-24.3%
29,879
-0.8%
0.00%
Q4 2021$325,000
-10.7%
30,128
-0.2%
0.00%
Q3 2021$364,000
+200.8%
30,181
+200.5%
0.00%
Q2 2021$121,00010,0420.00%
Other shareholders
AMRYT PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders